Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

被引：52

作者：

Tsuboi, A. ^{[1
]}

Oka, Y. ^{[2
]}

Kyo, T. ^{[3
,4
]}

Katayama, Y. ^{[3
,4
]}

Elisseeva, O. A. ^{[5
]}

Kawakami, M. ^{[6
]}

Nishida, S. ^{[1
]}

Morimoto, S. ^{[2
]}

Murao, A. ^{[2
]}

Nakajima, H. ^{[7
]}

Hosen, N. ^{[7
]}

Oji, Y. ^{[7
]}

Sugiyama, H. ^{[5
]}

机构：

[1] Osaka Univ, Dept Canc Immunotherapy, Grad Sch Med, Suita, Osaka, Japan

[2] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Reumat Dis, Suita, Osaka, Japan

[3] Atom Bomb Survivors Hosp, Hiroshima, Japan

[4] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan

[5] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka, Japan

[6] Nissay Hosp, Dept Hematol, Nishi Ku, Osaka, Japan

[7] Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan

来源：

LEUKEMIA | 2012年 / 26卷 / 06期

关键词：

CYTOTOXIC T-LYMPHOCYTES; INDUCTION; MALIGNANCIES; CELLS;

D O I：

10.1038/leu.2011.343

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1410 / 1413

页数：5

共 11 条

[1] Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study [J].

Cilloni, Daniela ;

Renneville, Aline ;

Hermitte, Fabienne ;

Hills, Robert K. ;

Daly, Sarah ;

Jovanovic, Jelena V. ;

Gottardi, Enrico ;

Fava, Milena ;

Schnittger, Susanne ;

Weiss, Tamara ;

Izzo, Barbara ;

Nomdedeu, Josep ;

van der Heijden, Adrian ;

van der Reijden, Bert A. ;

Jansen, Joop H. ;

van der Velden, Vincent H. J. ;

Ommen, Hans ;

Preudhomme, Claude ;

Saglio, Giuseppe ;

Grimwade, David .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5195-5201

[2] A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS [J].

Keilholz, Ulrich ;

Letsch, Anne ;

Busse, Antonia ;

Asemissen, Anne Marie ;

Bauer, Sandra ;

Blau, Igor Wolfgang ;

Hofmann, Wolf-Karsten ;

Uharek, Lutz ;

Thiel, Eckhard ;

Scheibenbogen, Carmen .

BLOOD, 2009, 113 (26) :6541-6548

[3] Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity [J].

Mailänder, V ;

Scheibenbogen, C ;

Thiel, E ;

Letsch, A ;

Blau, IW ;

Keilholz, U .

LEUKEMIA, 2004, 18 (01) :165-166

[4] The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia [J].

Ogawa, H ;

Tamaki, H ;

Ikegame, K ;

Soma, T ;

Kawakami, M ;

Tsuboi, A ;

Kim, EH ;

Hosen, N ;

Murakami, M ;

Fujioka, T ;

Masuda, T ;

Taniguchi, Y ;

Nishida, S ;

Oji, Y ;

Oka, Y ;

Sugiyama, H .

BLOOD, 2003, 101 (05) :1698-1704

[5]

Ohminami H, 2000, BLOOD, V95, P286

[6] Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression [J].

Oka, Y ;

Tsuboi, A ;

Taguchi, T ;

Osaki, T ;

Kyo, T ;

Nakajima, H ;

Elisseeva, OA ;

Oji, Y ;

Kawakami, M ;

Ikegame, K ;

Hosen, N ;

Yoshihara, S ;

Wu, F ;

Fujiki, F ;

Murakami, M ;

Masuda, T ;

Nishida, S ;

Shirakata, T ;

Nakatsuka, S ;

Sasaki, A ;

Udaka, K ;

Dohy, H ;

Aozasa, K ;

Noguchi, S ;

Kawase, L ;

Sugiyama, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) :13885-13890

[7] Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies [J].

Rezvani, Katayoun ;

Yong, Agnes S. M. ;

Mielke, Stephan ;

Savani, Bipin N. ;

Musse, Laura ;

Superata, Jeanine ;

Jafarpour, Behnam ;

Boss, Carol ;

Barrett, A. John .

BLOOD, 2008, 111 (01) :236-242

[8] WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy [J].

Sugiyama, Haruo .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (05) :377-387

[9] Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies [J].

Tanaka-Harada, Yukie ;

Kawakami, Manabu ;

Oka, Yoshihiro ;

Tsuboi, Akihiro ;

Katagiri, Takamasa ;

Elisseeva, Olga A. ;

Nishida, Sumiyuki ;

Shirakata, Toshiaki ;

Hosen, Naoki ;

Fujiki, Fumihiro ;

Murao, Ayako ;

Nakajima, Hiroko ;

Oji, Yusuke ;

Kanda, Yoshinobu ;

Kawase, Ichiro ;

Sugiyama, Haruo .

CANCER SCIENCE, 2010, 101 (03) :594-600

[10] Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues [J].

Tsuboi, A ;

Oka, Y ;

Udaka, K ;

Murakami, M ;

Masuda, T ;

Nakano, A ;

Nakajima, H ;

Yasukawa, M ;

Hiraki, A ;

Oji, Y ;

Kawakami, M ;

Hosen, N ;

Fujioka, T ;

Wu, F ;

Taniguchi, Y ;

Nishida, S ;

Asada, M ;

Ogawa, H ;

Kawase, I ;

Sugiyama, H .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (11-12) :614-620

← 1 2 →